<ARTICLE> 5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company for the period ended 9/30/97 </LEGEND> <MULTIPLIER> 1000000 <PERIOD-TYPE> 9-Mos <FISCAL-YEAR-END> Dec-31-1997<F1> <PERIOD-END> Sep-30-1997 <CASH> 1664 <SECURITIES> 304 <RECEIVABLES> 2806<F2> <ALLOWANCES> 0 <INVENTORY> 1819 <CURRENT-ASSETS> 7657 <PP&E> 6785 <DEPRECIATION> 2791 <TOTAL-ASSETS> 14718 <CURRENT-LIABILITIES> 4708 <BONDS> 1265 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 108 <OTHER-SE> 6819 <TOTAL-LIABILITY-AND-EQUITY> 14718 <SALES> 12260 <TOTAL-REVENUES> 12260 <CGS> 3285 <TOTAL-COSTS> 3285 <OTHER-EXPENSES> 2597 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 78 <INCOME-PRETAX> 3361 <INCOME-TAX> 958 <INCOME-CONTINUING> 2403 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 2403 <EPS-PRIMARY> 2.41 <EPS-DILUTED> 0 <FN> <F1>Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2>Receivables are reported net of allowances for doubtful accounts.